New AI model accurately classifies colorectal polyps using slides from 24 institutions

April 23, 2020

LEBANON, NH - Colorectal cancer is estimated to cause more than 53,000 deaths in the US in 2020, making it the second most common cause of cancer death. This death rate, however, has been steadily dropping, likely due to better cancer screening programs such as colonoscopy. During colonoscopies, clinicians excise colorectal polyps and visually examine them on histopathology slides for neoplasia. Detecting cancer at an early, curable stage and removing pre-invasive adenomas or serrated lesions ultimately reduces the mortality rate. Numbers and types of polyps found can also indicate future risk for malignancies and are therefore used as the basis for screening recommendations.

An artificial intelligence (AI) model for automated classification of colorectal polyps could benefit cancer screening programs by improving efficiency, reproducibility, and accuracy, as well as reducing access barriers to pathological services. In a new study out of Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center, a computer science and clinical research team led by Saeed Hassanpour, PhD, trained a deep neural network to do just that. Not only can their model distinguish the four major types of colorectal polyps at the level of practicing pathologists, as evaluated on a dataset across multiple external institutions, but also proves that a model designed using data from a single institution can achieve high accuracy on outside data.

The team found that a deep neural network, trained on colorectal polyp data from Dartmouth-Hitchcock Medical Center, still performed with the same level of sensitivity and accuracy as practicing pathologists when used on 238 slides spanning 24 different institutions in the US. These findings, "Evaluation of a Deep Neural Network for Automated Classification of Colorectal Polyps on Histopathology Slides," have been published in JAMA Network Open. "Our study is one of the first to show a deep neural network that is generalizable to data from multiple external medical centers," says Hassanpour. "A challenge in the field of deep learning for medical image analysis is collecting widespread data. Here, we have access to histopathology slides from 24 different institutions, which gave us the opportunity to evaluate and show that the AI models that we train are broadly generalizable to new data from outside."

The access to a multi-institutional dataset was made possible by Hassanpour's collaboration with Dr. Arief Suriawinata, MD, and his group from the Department of Pathology & Laboratory Medicine at Dartmouth-Hitchcock Medical Center and Dr. Elizabeth Barry, PhD, from the Department of Epidemiology at the Geisel School of Medicine at Dartmouth, as well as her colleagues from the Vitamin D/Calcium Polyp Prevention Clinical Trial.

Hassanpour's team has built a graphical user interface for showing the classifications of the neural network. They are currently working on a clinical trial to evaluate the use of their algorithm for assisting pathologists in diagnosis of colorectal polyps. "We are hoping to create a software application that can help pathologists improve their accuracy, efficiency, and consistency in diagnosing slides," he says.
-end-
Saeed Hassanpour, PhD, is an Associate Professor of Biomedical Data Science and Associate Professor of Epidemiology at the Geisel School of Medicine at Dartmouth, Associate Professor of Computer Science at Dartmouth's College of Arts and Sciences, and member of the Cancer Population Science Research Program at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center. His research interests include biomedical informatics, machine learning, and personalized medicine. https://www.hassanpourlab.com/@SaeedHP

About Norris Cotton Cancer Center

Norris Cotton Cancer Center, located on the campus of Dartmouth-Hitchcock Medical Center (DHMC) in Lebanon, NH, combines advanced cancer research at Dartmouth College's Geisel School of Medicine in Hanover, NH with the highest level of high-quality, innovative, personalized, and compassionate patient-centered cancer care at DHMC, as well as at regional, multi-disciplinary locations and partner hospitals throughout NH and VT,. NCCC is one of only 51 centers nationwide to earn the National Cancer Institute's prestigious "Comprehensive Cancer Center" designation, the result of an outstanding collaboration between DHMC, New Hampshire's only academic medical center, and Dartmouth College. Now entering its fifth decade, NCCC remains committed to excellence, outreach and education, and strives to prevent and cure cancer, enhance survivorship and to promote cancer health equity through its pioneering interdisciplinary research. Each year the NCCC schedules 61,000 appointments seeing nearly 4,000 newly diagnosed patients, and currently offers its patients more than 100 active clinical trials.

Dartmouth-Hitchcock Medical Center

Related Colorectal Polyps Articles from Brightsurf:

Experts release new management strategies for malignant colorectal polyps
Early identification and removal of cancerous colorectal polyps is critical to preventing the progression of colorectal cancer and improving survival rates.

New AI model accurately classifies colorectal polyps using slides from 24 institutions
Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have trained a deep neural network to distinguish the four major types of colorectal polyps excised during screening colonoscopy.

Researchers describe new condition involving numerous GI polyps in cancer survivors
Dana-Farber Cancer Institute researchers report newly discovered condition known as therapy-associated polyposis, or TAP in which childhood cancer survivors develop numerous colorectal growths called polyps.

New material could make it easier to remove colon polyps
MIT researchers have developed a gel that can be injected into the tissue lining the colon, forming a 'cushion' that makes it easier to remove precancerous polyps during a colonoscopy.

Fidarestat prevents high-fat diet-induced intestinal polyps in ApcMin/+ mice
Recent epidemiological and experimental studies have shown that obesity is a major risk factor for Colorectal Cancer (CRC).

Aspirin and omega-3 reduce pre-cancerous bowel polyps
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

A deep look at nasal polyps offers insights into allergic diseases
Investigators from Brigham and Women's Hospital, along with collaborators from the Broad Institute and MIT, have used some of the most advanced sequencing technology to peer into nasal polyps, gleaning new insights not only into this condition but also the severe form of inflammation that may lead to other disorders, such as asthma, allergic rhinitis and allergic eczema.

Polyps will let unrelated 'others' fuse to them and share tissue, scientists discover
University of Kansas scientists discovered that polyps have no qualms about treating a nonrelated individual like part of the family.

Penn researchers identify source of molecule linked to nasal polyps, asthma attacks
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies.

Blue dye tablet helps identify polyps during colonoscopy
Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer (CRC).

Read More: Colorectal Polyps News and Colorectal Polyps Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.